Upgrade to SI Premium - Free Trial

Viridian Therapeutic (VRDN) PT Lowered to $29 at Jefferies

March 30, 2026 1:02 PM
Jefferies analyst Faisal Khurshid lowered the price target on Viridian Therapeutic (NASDAQ: VRDN) to $29.00 (from $45.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change